Tharimmune (THAR) Institutional Ownership $3.99 -0.78 (-16.35%) Closing price 04:00 PM EasternExtended Trading$4.12 +0.14 (+3.38%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tharimmune (NASDAQ:THAR)CurrentInstitutional OwnershipPercentage1.16%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$214.32KNumber ofInstitutional Sellers(last 12 months)0 Get THAR Insider Trade Alerts Want to know when executives and insiders are buying or selling Tharimmune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data THAR Institutional Buying and Selling by Quarter Tharimmune Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/12/2025 XTX Topco Ltd12,911$25K0.0%N/A0.306% 8/12/2025 Franklin Resources Inc.45,000$88K0.0%N/A1.066% 2/11/2025 Virtu Financial LLC21,371$44K0.0%N/A1.107% 11/6/2024 Curi RMB Capital LLC23,620$59K0.0%N/A2.056% 5/12/2022 Murchinson Ltd.116,029$186K0.0%N/A1.021% (Data available from 1/1/2016 forward) THAR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of THAR shares? During the previous two years, the following institutional investors and hedge funds held shares of Tharimmune shares: Franklin Resources Inc. ($88K), Curi RMB Capital LLC ($59K), and Virtu Financial LLC ($44K), XTX Topco Ltd ($25K).Learn more on Tharimmune's institutional investors. What percentage of Tharimmune's stock is owned by institutional investors? 1.16% of Tharimmune's stock is owned by institutional investors. Learn more on THAR's institutional investor holdings. Which institutional investors have been buying Tharimmune's stock? The following institutional investors have purchased Tharimmune's stock in the last 24 months: Franklin Resources Inc. ($45K), Curi RMB Capital LLC ($23.62K), Virtu Financial LLC ($21.37K), and XTX Topco Ltd ($12.91K). How much institutional buying is happening at Tharimmune? Institutional investors have bought a total of 102,902 shares in the last 24 months. This purchase volume represents approximately $214.32K in transactions. Related Companies Surrozen Institutional Ownership Cassava Sciences Institutional Ownership TScan Therapeutics Institutional Ownership KALA BIO Institutional Ownership HilleVax Institutional Ownership Pliant Therapeutics Institutional Ownership Skye Bioscience Institutional Ownership Adagene Institutional Ownership Anebulo Pharmaceuticals Institutional Ownership Atossa Genetics Institutional Ownership This page (NASDAQ:THAR) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tharimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tharimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.